NU-biblioteket
 
Alzheimer's disease : life course perspectives on risk reduction
Komihåglistan är tom
Vis
Huvuduppslag - Personnamn
Titel och upphov
  • Alzheimer's disease : life course perspectives on risk reduction
Antal i kö: NU (US)
  • 0 (0)
Utgivning, distribution, etc.
  • Academic Press is an imprint of Elsevier, Amsterdam : [2016] ©2016
National Library of Medicine (NLM) klassifikationskod
  • WT 155
DDC klassifikationskod (Dewey Decimal Classification)
Fysisk beskrivning
  • 1 online resource (xvi, 352 pages) : illustrations, portraits
Serietitel - ej biuppslagsform
Anmärkning: Bibliografi etc.
  • Includes bibliographical references and index.
Anmärkning: Innehåll
  • The "first" case -- Clinical appearance, progression, and classification -- Epidemiologic definition of a case -- Neuropathology of Alzheimer's disease -- The threshold model of dementia -- The prevalence of Alzheimer's disease -- The incidence of Alzheimer's disease -- Survival and mortality in Alzheimer's disease -- Introduction to the analytic epidemiology of Alzheimer's disease -- Family history, genetics, and down syndrome -- Early-life factors -- Traumatic brain injury -- Cigarette smoking and alcohol consumption -- Vascular disease -- Diet -- Physical activity -- Cognitive activity -- Social engagement -- Nonsteroidal anti-inflammatory drugs, hormone replacement therapy, and anticholinergic medications -- Prodromal markers of disease or causal risk factors? Depression, olfaction, and subjective memory complaints -- Fluid, imaging, and cognitive biomarkers -- Risk assessment and prevention of Alzheimer's disease -- Summary and recommendations.
Anmärkning: Innehållsbeskrivning, sammanfattning
  • Alzheimer's Disease: Lifecourse Perspectives on Risk Reduction summarizes the growing body of knowledge on the distribution and causes of Alzheimer's disease (AD) in human populations, providing the reader with knowledge on how we define the disease and what its risk and protective factors are in the context of a life-course approach. At the conclusion of the book, the reader will understand why Alzheimer's disease likely begins at conception, then progresses through early-life and adult risk factors that ultimately impact the balance between pathologic insults in the brain and the ability of the brain to modify disease symptoms. In contrast to edited volumes that may have little cohesion, this book focuses on an integrated life-course approach to the epidemiology of dementia, in particular, Alzheimer's disease.
Ämnesordsbiuppslag - Term
Indexterm - Genre/Form
  • Electronic books.
  • Electronic books.
Biuppslag - Personnamn
Länkfält - Annat medium
  • Print version: Borenstein, Amy R. Alzheimer's disease. Amsterdam ; Boston : Elsevier/AP, Academic Press is an imprint of Elsevier, [2016] ISBN 9780128045381
Seriebiuppslag under titel
  • ClinicalKey.
ISBN
  • 9780124171541
  • 0124171540
 
*00000000cam a2200000Ii 4500
*00171406
*00520210409104438.5
*006m     o  d
*007cr |n|||||||||
*008160219t20162016ne ac   ob    001 0 eng d
*019  $a941696187$a993971625
*020  $a9780124171541$q(electronic bk.)
*020  $a0124171540$q(electronic bk.)
*020  $z9780128045381$q(print)
*020  $z0128045388$q(print)
*029  $aCHVBK$b403940109
*029  $aCHBIS$b010796199
*029  $aGBVCP$b879391871
*029  $aAU@$b000060846422
*035  $a(OCoLC)939960491$z(OCoLC)941696187$z(OCoLC)993971625
*035  $a(OCoLC)ocn939960491
*040  $aN$beng$erda$epn$cN$dN$dYDXCP$dIDEBK$dOPELS$dUIU$dCDX$dEBLCP$dCOO$dUAB$dZ5A$dUSU$dMMU$dOCLCO$dBUF$dMERER$dOCLCO$dUIU$dOCLCQ$dOCLCA$dLEATE$dOCLCA$dU3W$dOCLCA$dOCLCQ$dOCLCF$dOCLCO$dFQM$dOCLCQ$dOCLCO$dAU@$dOCLCO$dOCLCQ$dNJT$dOCLCO$dOCLCQ$dOCLCA$dOCLCQ
*049  $aMAIN
*050 4$aRC523
*060 4$aWT 155
*072 7$aHEA$x039000$2bisacsh
*072 7$aMED$x014000$2bisacsh
*072 7$aMED$x022000$2bisacsh
*072 7$aMED$x112000$2bisacsh
*072 7$aMED$x045000$2bisacsh
*08204$a616.8/31$223
*100  $aBorenstein, Amy R.,$eauthor.
*24510$aAlzheimer's disease :$blife course perspectives on risk reduction /$cAmy R. Borenstein, Ph.D., M.P.H. and James A. Mortimer, Ph.D., University of South Florida, Department of Epidemiology and Biostatistics, Department of Neurology, Tampa, FL, USA.
*264 1$aAmsterdam :$bAcademic Press is an imprint of Elsevier,$c[2016]
*264 4$c©2016
*300  $a1 online resource (xvi, 352 pages) :$billustrations, portraits
*336  $atext$btxt$2rdacontent
*337  $acomputer$bc$2rdamedia
*338  $aonline resource$bcr$2rdacarrier
*347  $atext file$bPDF$2rda
*347  $atext file$bhtml$2rda
*490  $aClinicalKey
*504  $aIncludes bibliographical references and index.
*505 0$aThe "first" case -- Clinical appearance, progression, and classification -- Epidemiologic definition of a case -- Neuropathology of Alzheimer's disease -- The threshold model of dementia -- The prevalence of Alzheimer's disease -- The incidence of Alzheimer's disease -- Survival and mortality in Alzheimer's disease -- Introduction to the analytic epidemiology of Alzheimer's disease -- Family history, genetics, and down syndrome -- Early-life factors -- Traumatic brain injury -- Cigarette smoking and alcohol consumption -- Vascular disease -- Diet -- Physical activity -- Cognitive activity -- Social engagement -- Nonsteroidal anti-inflammatory drugs, hormone replacement therapy, and anticholinergic medications -- Prodromal markers of disease or causal risk factors? Depression, olfaction, and subjective memory complaints -- Fluid, imaging, and cognitive biomarkers -- Risk assessment and prevention of Alzheimer's disease -- Summary and recommendations.
*520  $aAlzheimer's Disease: Lifecourse Perspectives on Risk Reduction summarizes the growing body of knowledge on the distribution and causes of Alzheimer's disease (AD) in human populations, providing the reader with knowledge on how we define the disease and what its risk and protective factors are in the context of a life-course approach. At the conclusion of the book, the reader will understand why Alzheimer's disease likely begins at conception, then progresses through early-life and adult risk factors that ultimately impact the balance between pathologic insults in the brain and the ability of the brain to modify disease symptoms. In contrast to edited volumes that may have little cohesion, this book focuses on an integrated life-course approach to the epidemiology of dementia, in particular, Alzheimer's disease.
*588  $aOnline resource; title from resource home page (ClinicalKey, viewed June 20, 2017).
*650 0$aAlzheimer's disease$xEpidemiology.
*650 0$aAlzheimer's disease$xPrevention.
*650 2$aAlzheimer Disease$xepidemiology.
*650 7$aHEALTH & FITNESS / Diseases / General$2bisacsh
*650 7$aMEDICAL / Clinical Medicine$2bisacsh
*650 7$aMEDICAL / Diseases$2bisacsh
*650 7$aMEDICAL / Evidence-Based Medicine$2bisacsh
*650 7$aMEDICAL / Internal Medicine$2bisacsh
*650 7$aAlzheimer's disease$xPrevention.$2fast$0(OCoLC)fst00806584
*655 0$aElectronic books.
*655 4$aElectronic books.
*700  $aMortimer, James A.,$eauthor.
*77608$iPrint version:$aBorenstein, Amy R.$tAlzheimer's disease.$dAmsterdam ; Boston : Elsevier/AP, Academic Press is an imprint of Elsevier, [2016]$z9780128045381$wIMP(OCoLC)(DLC)  2015955068$w(OCoLC)926742871
*830 0$aClinicalKey.
*85640$uhttp://proxybibl.vgregion.se/login?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20130097009$zTillgänglig via e-biblioteket Västra Götalandsregionen
*994  $a92$bSENUS
^
Det finns inga omdömen till denna titeln.
Klicka här för att vara den första som skriver ett omdöme.
Vis
Sänd till